# Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients

> **NCT01568047** · PHASE2 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 40 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** BIA 9-1067
- **DRUG:** BIA 9-1067
- **DRUG:** BIA 9-1067
- **DRUG:** Levodopa/Carbidopa
- **DRUG:** Levodopa/Benzerazide

## Key facts

- **NCT ID:** NCT01568047
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568047, "Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01568047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*